Drug intelligence / Profile preview

Lactobacillus paracasei GMNL-346

Development stage: Unknown
Lead developer: GenMont Biotech
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

GMNL-346 is a proprietary probiotic strain of *Lactobacillus paracasei* developed by GenMont Biotech, a Taiwan-based company specializing in functional probiotics. Administered orally via capsules or sachets, GMNL-346 is designed to support gastrointestinal wellness and maintain a healthy gut microbiome. Its mechanism of action involves the modulation of the intestinal microbiota, competitive inhibition of pathogenic bacteria, and potential enhancement of the intestinal mucosal barrier. In addition to its primary use for gut health, research has also explored its role in metabolic health, including the management of blood sugar and lipid levels. It is primarily marketed as a functional food ingredient and dietary supplement rather than a conventional pharmaceutical agent.

Other names: Lactobacillus paracasei GMNL-346

Beyond the preview

Go deeper on Lactobacillus paracasei GMNL-346.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus paracasei GMNL-346.

Explore the full profile